CORRELATION OF THE INSULIN RECEPTOR EXPRESSION AND THE RESISTANCE TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA

被引：0
|
作者：
Takahashi, Masayuki
Daizumoto, Kei
Fukuhara, Yayoi
Ozaki, Keisuke
Tsuda, Megumi
Kusuhara, Yoshito
Mori, Hidehisa
Fukawa, Tomoya
Yamamoto, Yasuyo
Yamaguchi, Kunihisa
Fukumori, Tomoharu
Kanayama, Hiroomi
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP72-06
引用
收藏
页码：E954 / E954
页数：1
相关论文
共 50 条
  • [1] Targeting androgen receptor overcomes resistance to tyrosine kinase inhibitors in advanced clear cell renal cell carcinoma
    Adelaiye-Ogala, Remi M.
    Chintala, Sreenivasulu
    Orillion, Ashley
    Elbanna, May
    Elzey, Ben
    Damayanti, Nur
    Miles, Kiersten M.
    Kao, Chinghai
    Pettazzoni, Piergiorgio
    Draetta, Giulio F.
    Pili, Roberto
    CANCER RESEARCH, 2017, 77
  • [2] Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma
    Franczyk, Beata
    Rysz, Jacek
    Lawinski, Janusz
    Cialkowska-Rysz, Aleksandra
    Gluba-Brzozka, Anna
    BIOMEDICINES, 2023, 11 (01)
  • [3] A comparison of combined immune checkpoint inhibitors (IO) versus vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) in the treatment of advanced clear cell renal cell carcinoma
    Chan, Abigail Sy
    Pond, Gregory Russell
    Sonpavde, Guru
    Alva, Ajjai Shivaram
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [4] The significance of insulin receptor expression in vascular endothelial cells of clear cell renal cell carcinoma
    Takahashi, Masayuki
    Daizumoto, Kei
    Fukuhara, Yayoi
    Kowada, Minoru
    Bando, Yoshimi
    Fukawa, Tomoya
    Fukumori, Tomoharu
    Kanayama, Hiro-omi
    CANCER SCIENCE, 2018, 109 : 982 - 982
  • [5] Correlation of Degree of Hypothyroidism With Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors
    Bailey, Erin B.
    Tantravahi, Srinivas K.
    Poole, Austin
    Agarwal, Archana M.
    Straubhar, Alli M.
    Batten, Julia A.
    Patel, Shiven B.
    Wells, Chesley E.
    Stenehjem, David D.
    Agarwal, Neeraj
    CLINICAL GENITOURINARY CANCER, 2015, 13 (03) : E131 - E137
  • [6] Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Basappa, Naveen S.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2016, 10 (11-12): : S242 - S244
  • [7] Sarcomatoid Dedifferentiation in Metastatic Clear Cell Renal Cell Carcinoma and Outcome on Treatment With Anti-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: A Retrospective Analysis
    Beuselinck, Benoit
    Lerut, Evelyne
    Wolter, Pascal
    Dumez, Herlinde
    Berkers, Johannes
    Van Poppel, Hendrik
    Joniau, Steven
    Oyen, Raymond
    De Wever, Liesbeth
    Strijbos, Michiel
    Paridaens, Robert
    Schoffski, Patrick
    CLINICAL GENITOURINARY CANCER, 2014, 12 (05) : E205 - E214
  • [8] Prognostic tissue biomarker exploration for patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Park, Inkeun
    Cho, Yong Mee
    Lee, Jae-Lyun
    Ahn, Jin-Hee
    Lee, Dae-Ho
    TUMOR BIOLOGY, 2016, 37 (04) : 4919 - 4927
  • [9] Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features
    Jae-Lyun Lee
    Inkeun Park
    Kwonoh Park
    Seongjoon Park
    Yongcheol Ahn
    Jin-Hee Ahn
    Tae-Won Kim
    Shin Ahn
    Cheryn Song
    Jun Hyuk Hong
    Choung-Soo Kim
    Hanjong Ahn
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 687 - 693
  • [10] Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features
    Lee, Jae-Lyun
    Park, Inkeun
    Park, Kwonoh
    Park, Seongjoon
    Ahn, Yongcheol
    Ahn, Jin-Hee
    Kim, Tae-Won
    Ahn, Shin
    Song, Cheryn
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (04) : 687 - 693
12345